Members of the group have over two decades of experience in patent and trade mark protection and an impressive track record of representing clients in the field of biological sciences in connection with all aspects of IP.Â We have recruited people with advanced academic degrees, many with direct industry experience in this sector, which allows us to serve the full spectrum of clients in the biotechnology sector, from universities through to investors, innovative start-ups and multinational brands.
We offer our clients a complete range of IP services, Â including evaluation of IP opportunities, global filing and prosecution strategy, drafting, prosecution, opposition, validity, freedom-to-operate, competitor monitoring, and licensing.
Our commercial understanding of the sector has successfully taken clients from the spin-out stage to multi-million pound funding projects and helped us to secure innovative licensing deals
Being a part of this global community is important to us and we support a number of key events each year. We also regularly contribute to a number of industry publications.
The business of precision medicine â€“ visioning the Future
We are pleased to be Gold Sponsors of theÂ inaugural Bionow Precision Medicine Conference. Hosted in Leeds on 5th April, the conference will explore the impact that developments in this area is having on patients, particulaly in the areas of inflammatory disease, cancer, cardiovascular / metabolic, infection, health economics and clinical trials. To read more please click here.Â
Make sure to pop down to meet the team at BioTrinity at stand number 26. taking BioTrinity is one of Europe's leading industry networking and partnering conference, and is takingÂ place in London from 8th - 10th May. To read more about the conference please click here.Â
We are proud sponsors of ON Helix, a conference that aims to help delegatesÂ turn early stage inventions and ideas into innovative health treatments. Martin MacLean and Craig Titmus will be attending the conference that takes place on 13th July in Cambridge.Â
The Nagoya Protocol â€“ A Practical Overview
David Hobson has co-authored a publicationÂ The Nagoya Protocol â€“ A Practical Overview, Thomas BjÃ¸rn & David Hobson, Copenhagen Life Science (September/October 2015).Â The Nagoya Protocol aims to regulate the access to genetic resources and to ensure the fair and equitable sharing of benefits arising from their utilisation.